glioblastoma multiforme

Ziopharm Phase I Trial Yields Positive Results for Treatment of rGBM
Ziopharm Phase I Trial Yields Positive Results for Treatment of rGBM
BioSpace
Ziopharm Oncology
rGBM
ASCO 2020
glioblastoma multiforme
clinical trials
Flag link:
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Yahoo/Reuters
Bristol-Myers Squibb
Opdivo
clinical trials
glioblastoma multiforme
Flag link:
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
CP Wire
Enterome
immuno-oncology
glioblastoma multiforme
molecular mimicry
Flag link:
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Enterome
immuno-oncology
glioblastoma multiforme
Flag link:
Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Drug Delivery Business News
Novocure
Optune
glioblastoma multiforme
Flag link:
Novogen irons out Phase 2 plans for brain cancer candidate
Novogen irons out Phase 2 plans for brain cancer candidate
BioPharma Dive
Novagen
clinical trials
GDC-0084
glioblastoma multiforme
brain cancer
Flag link:
Tracon Tanks on Brain Cancer Drug Failure
Tracon Tanks on Brain Cancer Drug Failure
Investopedia
TRACON Pharmaceuticals
glioblastoma multiforme
brain cancer
TRC105
Flag link:
Northwest Bio Spikes on Lifting of Clinical Hold
Northwest Bio Spikes on Lifting of Clinical Hold
Investopedia
Northwest Biotherapeutics
DCVax-L
glioblastoma multiforme
brain cancer
Flag link:
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
TheStreet.com
Celldex Therapeutics
clinical trials
Rintega
glioblastoma multiforme
Flag link:
NovoCure’s cancer therapy effective in late-stage study
NovoCure’s cancer therapy effective in late-stage study
Mass Device
Novocure
Optune
brain cancer
glioblastoma multiforme
devices
Flag link:
Celldex vaccine improves long-term brain cancer survival in study
Celldex vaccine improves long-term brain cancer survival in study
Yahoo/Reuters
Celldex
vaccines
brain cancer
glioblastoma multiforme
Rintega
Flag link:
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
Flag link:
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
Fierce Biotech
ASCO
Celldex
glioblastoma multiforme
brain cancer
Rintega
Flag link:
Novogen Makes Big Step In Fighting Brain Cancer
Novogen Makes Big Step In Fighting Brain Cancer
24/7 Wall St
Novogen
TRXE-009
glioblastoma multiforme
brain cancer
Flag link:
Celldex Therapeutics To Enter Talks With FDA
Celldex Therapeutics To Enter Talks With FDA
Seeking Alpha
Celldex Therapeutics
FDA
GBM
rindopepimut
glioblastoma multiforme
Flag link:
FDA grants orphan drug designation to potential Insys brain cancer treatment
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Insys
orphan drugs
FDA
CBD
glioblastoma multiforme
Flag link:
AbbVie makes inroads in orphan drugs
AbbVie makes inroads in orphan drugs
Medical Marketing and Media
AbbVie
orphan drugs
glioblastoma multiforme
ABT-414
Flag link:
Northwest Bio DC-Vax Study Changes Hint at Failure
Northwest Bio DC-Vax Study Changes Hint at Failure
TheStreet.com
Northwest Biotherapeutics
DCVax
vaccines
glioblastoma multiforme
Flag link:
Agenus brain cancer vaccine nearly doubles survival rate in study
Agenus brain cancer vaccine nearly doubles survival rate in study
Yahoo/Reuters
Agenus
brain cancer
vaccines
glioblastoma multiforme
Flag link:
AbbVie heralds early success with its brain cancer-fighting armed antibody
AbbVie heralds early success with its brain cancer-fighting armed antibody
Fierce Biotech
glioblastoma multiforme
ABT-414
AbbVie
Flag link:

Pages